BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22679001)

  • 1. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.
    Zhang X; Bai Q; Xu L; Kakiyama G; Pandak WM; Zhang Z; Ren S
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G344-55. PubMed ID: 22679001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury.
    Wang Z; Yang X; Chen L; Zhi X; Lu H; Ning Y; Yeong J; Chen S; Yin L; Wang X; Li X
    Arch Toxicol; 2017 Jan; 91(1):271-287. PubMed ID: 27052460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.
    Bai Q; Zhang X; Xu L; Kakiyama G; Heuman D; Sanyal A; Pandak WM; Yin L; Xie W; Ren S
    Metabolism; 2012 Jun; 61(6):836-45. PubMed ID: 22225954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
    Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.
    Zhang X; Bai Q; Kakiyama G; Xu L; Kim JK; Pandak WM; Ren S
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):262-70. PubMed ID: 22732306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells.
    Bai Q; Xu L; Kakiyama G; Runge-Morris MA; Hylemon PB; Yin L; Pandak WM; Ren S
    Atherosclerosis; 2011 Feb; 214(2):350-6. PubMed ID: 21146170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxysteroid sulfotransferase SULT2B1b promotes hepatocellular carcinoma cells proliferation in vitro and in vivo.
    Yang X; Xu Y; Guo F; Ning Y; Zhi X; Yin L; Li X
    PLoS One; 2013; 8(4):e60853. PubMed ID: 23593328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation.
    Ren S; Ning Y
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E123-30. PubMed ID: 24302009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes.
    Jiang YJ; Kim P; Elias PM; Feingold KR
    J Lipid Res; 2005 Dec; 46(12):2657-66. PubMed ID: 16150827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and immunohistochemical localization of Sulfotransferase 2B1b (SULT2B1b) in human lung.
    He D; Frost AR; Falany CN
    Biochim Biophys Acta; 2005 Jun; 1724(1-2):119-26. PubMed ID: 15878639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SULT2B1b promotes epithelial-mesenchymal transition through activation of the β-catenin/MMP7 pathway in hepatocytes.
    Yang X; Du X; Sun L; Zhao X; Zhu J; Li G; Tian J; Li X; Wang Z
    Biochem Biophys Res Commun; 2019 Mar; 510(4):495-500. PubMed ID: 30658852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxysteroid sulfotransferase 2B1b expression and localization in normal human brain.
    Salman ED; Faye-Petersen O; Falany CN
    Horm Mol Biol Clin Investig; 2011 Oct; 8(1):445-454. PubMed ID: 24683427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice.
    Chen W; Chen G; Head DL; Mangelsdorf DJ; Russell DW
    Cell Metab; 2007 Jan; 5(1):73-9. PubMed ID: 17189208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Unexpected Role of Cholesterol Sulfotransferase and its Regulation in Sensitizing Mice to Acetaminophen-Induced Liver Injury.
    An Y; Wang P; Xu P; Tung HC; Xie Y; Kirisci L; Xu M; Ren S; Tian X; Ma X; Xie W
    Mol Pharmacol; 2019 Jun; 95(6):597-605. PubMed ID: 30944208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.
    Shi X; Cheng Q; Xu L; Yan J; Jiang M; He J; Xu M; Stefanovic-Racic M; Sipula I; O'Doherty RM; Ren S; Xie W
    Mol Cell Biol; 2014 Feb; 34(3):485-97. PubMed ID: 24277929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization.
    Falany CN; He D; Dumas N; Frost AR; Falany JL
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):214-21. PubMed ID: 17055258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes.
    Li X; Pandak WM; Erickson SK; Ma Y; Yin L; Hylemon P; Ren S
    J Lipid Res; 2007 Dec; 48(12):2587-96. PubMed ID: 17890683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced SULT2B1b expression alleviates ox-LDL-induced inflammation by upregulating miR-148-3P via inhibiting the IKKβ/NF-κB pathway in macrophages.
    Yin M; Lu J; Guo Z; Zhang Y; Liu J; Wu T; Guo K; Luo T; Guo Z
    Aging (Albany NY); 2021 Jan; 13(3):3428-3442. PubMed ID: 33428590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.
    Cook IT; Duniec-Dmuchowski Z; Kocarek TA; Runge-Morris M; Falany CN
    Drug Metab Dispos; 2009 Oct; 37(10):2069-78. PubMed ID: 19589875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.